total-news-1024x279-1__1_-removebg-preview.png

SELECT LANGUAGE BELOW

FDA appears poised to approve sickle cell gene therapy  

The medicine uses gene editing technology Developed through a collaboration between Vertex Pharmaceuticals and CRISPR Therapeutics. The FDA’s Cell, Tissue, and Gene Therapy Advisory Committee did not vote at Tuesday’s meeting, but positive discussions likely indicate the agency will make a favorable decision. “I think the benefits far outweigh the risks, especially when you consider […]